Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma

Author:

Long Georgina V.1ORCID,Hauschild Axel1,Santinami Mario1,Kirkwood John M.1,Atkinson Victoria1,Mandala Mario1,Merelli Barbara1,Sileni Vanna Chiarion1,Nyakas Marta1,Haydon Andrew1,Dutriaux Caroline1,Robert Caroline1,Mortier Laurent1,Schachter Jacob1,Schadendorf Dirk1ORCID,Lesimple Thierry1,Plummer Ruth1,Larkin James1,Tan Monique1,Adnaik Sachin Bajirao1,Burgess Paul1,Jandoo Tarveen1,Dummer Reinhard1

Affiliation:

1. From the Melanoma Institute Australia, the University of Sydney, Royal North Shore Hospital, and Mater Hospital, Sydney (G.V.L.), Princess Alexandra Hospital, the Gallipoli Medical Research Foundation, and the University of Queensland, Woolloongabba (V.A.), and Alfred Hospital, Melbourne, VIC (A.H.) — all in Australia; the Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel (A.H.), and the German Cancer Consortium, National Center for Tumor Diseases, University...

Funder

Novartis Pharma

Publisher

Massachusetts Medical Society

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3